Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 06-2014 | 06-2013 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,826 | N/A | 24,245 | 22,816 | 24,613 |
| Receivables | N/A | N/A | 7,568 | 12,308 | 8,869 |
| Inventories | N/A | N/A | 20,812 | 17,137 | 17,708 |
| Income taxes - deferred | N/A | N/A | 498 | 478 | 391 |
| Other current assets | 0 | 0 | 1,360 | 981 | 889 |
| TOTAL | $35,900 | $N/A | $54,483 | $53,720 | $52,470 |
| Non-Current Assets | |||||
| PPE Net | 1,387 | N/A | 5,544 | 4,922 | 4,860 |
| Intangibles | 0 | 0 | 23,399 | 24,194 | 25,129 |
| Other Non-Current Assets | 11,160 | 0 | 237 | 250 | 255 |
| TOTAL | $12,547 | $N/A | $29,180 | $29,366 | $30,244 |
| Total Assets | $48,447 | $N/A | $83,663 | $83,086 | $82,714 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,095 | 0 | 1,645 | 2,295 | 1,890 |
| Accrued Expenses | 2,866 | N/A | 3,861 | 3,712 | 2,735 |
| Other current liabilities | N/A | N/A | 2,810 | 1,715 | 1,700 |
| TOTAL | $8,656 | $N/A | $9,097 | $8,398 | $7,167 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 599 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 71 | 0 | 0 | 1,600 | 3,300 |
| TOTAL | $8,132 | $N/A | $2,171 | $3,979 | $5,729 |
| Total Liabilities | $16,788 | $N/A | $11,268 | $12,377 | $12,896 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 8,710 | 8,661 | 8,591 |
| Common Shares | N/A | N/A | 33,207 | 32,210 | 31,294 |
| Retained earnings | -47,671 | N/A | 41,114 | 40,425 | 40,450 |
| Other shareholders' equity | 77,505 | 0 | 74 | 74 | 74 |
| TOTAL | $31,659 | $N/A | $72,395 | $70,709 | $69,818 |
| Total Liabilities And Equity | $48,447 | $0 | $83,663 | $83,086 | $82,714 |